592P Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)

Autor: Schweizer, M., Gulati, R., Yezefski, T., Cheng, H., Sievers, C., Dumpit, R., Alexander, K., McDonald, N., Lai, M., Nega, K., Hammond, J., Grivas, P., Hsieh, A., Montgomery, B., Nelson, P., Yu, E.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S639-S640
Databáze: ScienceDirect